Cell Reports
Volume 30, Issue 12, 24 March 2020, Pages 4052-4064.e7
Journal home page for Cell Reports

Article
The Absence of HIF-1α Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis

https://doi.org/10.1016/j.celrep.2020.02.098Get rights and content
Under a Creative Commons license
open access

Highlights

  • HIF-1α is a protective factor against Leishmania donovani infection

  • In absence of HIF-1α, lipogenesis is induced via BNIP3/mTOR/SREBP-1c modulation

  • Blockage of lipogenesis reverts HIF-1α-associated Leishmania susceptibility

  • HIF1A polymorphism correlates with susceptibility to infection

Summary

Hypoxia-inducible factor-1 alpha (HIF-1α) is considered a global regulator of cellular metabolism and innate immune cell functions. Intracellular pathogens such as Leishmania have been reported to manipulate host cell metabolism. Herein, we demonstrate that myeloid cells from myeloid-restricted HIF-1α-deficient mice and individuals with loss-of-function HIF1A gene polymorphisms are more susceptible to L. donovani infection through increased lipogenesis. Absence of HIF-1α leads to a defect in BNIP3 expression, resulting in the activation of mTOR and nuclear translocation of SREBP-1c. We observed the induction of lipogenic gene transcripts, such as FASN, and lipid accumulation in infected HIF-1α−/− macrophages. L. donovani-infected HIF-1α-deficient mice develop hypertriglyceridemia and lipid accumulation in splenic and hepatic myeloid cells. Most importantly, our data demonstrate that manipulating FASN or SREBP-1c using pharmacological inhibitors significantly reduced parasite burden. As such, genetic deficiency of HIF-1α is associated with increased lipid accumulation, which results in impaired host-protective anti-leishmanial functions of myeloid cells.

Keywords

HIF-1α
visceral leishmaniasis
macrophages
lipogenesis
SREBP-1c
FASN
acetate
myeloid cells

Cited by (0)

16

Present address: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, 152-160 Pearce Street, Dublin 2, Ireland

17

Present address: Department of Biochemistry and Biomedical Sciences, Thrombosis and Atherosclerosis Research Institute (TaARI), David Braley Cardiac, Vascular and Stroke Research Institute, McMaster University, Hamilton General Hospital Campus, Hamilton Health Sciences, 237 Barton St. E., Hamilton, ON L8L 2X2, Canada

18

Lead Contact